Christensen, Ingrid Egeland https://orcid.org/0000-0002-8429-8152
Jyssum, Ingrid
Tveter, Anne Therese
Sexton, Joseph
Tran, Trung T.
Mjaaland, Siri
Kro, Grete Birkeland
Kvien, Tore K.
Warren, David John
Jahnsen, Jørgen
Munthe, Ludvig A.
Haavardsholm, Espen A.
Vaage, John Torgils
Grødeland, Gunnveig
Lund-Johansen, Fridtjof
Jørgensen, Kristin Kaasen
Syversen, Silje Watterdal
Goll, Guro Løvik
Provan, Sella Aarrestad
Funding for this research was provided by:
The Coalition for Epidemic Preparedness Innovations (RCN Covid (312693))
Helse Sør-Øst RHF (10357)
Dr Trygve Gythfeldt og Frues Forskningsfond
Karin Fossum Foundation
Research Foundation at Diakonhjemmet Hospital
Article History
Received: 11 February 2022
Accepted: 28 September 2022
First Online: 5 October 2022
Declarations
:
: Ethical approval for the Nor-vaC study was granted by the National Committee for Research Ethics (reference numbers: REK- 235424, REK-135924). Patients and healthy controls signed informed consent prior to inclusion.
: Not applicable.
: TKK reports grants from AbbVie, Amgen, BMS, MSD, Novartis, Pfizer, UCB, consulting fees from AbbVie, Amgen, Biogen, Celltrion, Eli Lilly, Gilead, Mylan, Novartis, Pfizer, Sandoz, Sanofi, speakers bureaus Amgen, Celltrion, Egis, Evapharma, Ewopharma, Hikma, Oktal, Sandoz, Sanofi. JJ reports grants from Abbvie, Pharmacosmos, Ferring, consulting fees from Abbvie, Boerhinger Ingelheim, BMS, Celltrion, Ferring, Glihead, Janssen Cilag, MSD, Napp Pharma, Novartis, Orion Pharma, Pfeizer, Pharmacosmos, Takeda, Sandoz, Unimedic Pharma, speakers bureaus Abbvie, Astro Pharma, Boerhinger Ingelheim, BMS, Celltrion, Ferring, Glihead, Hikma, Janssen Cilag, Meda, MSD, Napp Pharma, Novartis, Oriuon Pharma, Pfeizer, Pharmacosmos, Roche, Takeda, Sandoz. LAM reports funding from KG Jebsen foundation, support for infrastructure and biobanking from the University of Oslo and Oslo University Hospital, grants from the Coalition of Epidemic Preparedness Innovations CEPI, speakers bureaus Novartis, Cellgene. JTV reports grant from the Coalition of Epidemic Preparedness Innovations (CEPI). GG reports consulting fees from the Norwegian System of Compensation to Patients, AstraZeneca, speakers bureaus Bayer, Sanofi Pasteur, and Thermo Fisher. FLJ reports grant from the Coalition of Epidemic Preparedness Innovations (CEPI), grant from South-East region Health authority. KKJ reports speakers bureaus from Roche and BMS, advisory board Celltrion and Norgine. GLG reports funding from The Karin Fossum foundation, Diakonhjemmet Hospital, Oslo University Hospital, Akershus University Hospital, Trygve Gydtfeldt og frues Foundation, South-East region Health authority, consulting fees AbbVie and Pfizer, speaker’s fees AbbVie, Pfizer, Sandoz, Orion Pharma, Novartis and UCB, advisory board Pfizer, AbbVie. IEC, IJ, SWS, ATT, TTT, JS, SAP, SM, DJW, GBK, and EAH report nothing to disclose.